3Suppliers
1Customers
2Debt Items
0Related Chains

Silo Pharma, Inc. Suppliers

TickerNameConfidenceEvidence
BLIND-FAITH-CONCEPTS-HOLDINGS-INC BLIND-FAITH-CONCEPTS-HOLDINGS-INC 92% On September 29, 2018, we entered into an Asset Purchase Agreement with Blind Faith Concepts Holdings, Inc. pursuant to which we completed the acquisition of 100% of the assets of NFID from the seller
MANY-ADS-INC MANY-ADS-INC 92% Pursuant to the Agreement, the Seller agreed to sell, and the Company agreed to purchase, certain software of the web-based application currently marketed as "QwikAgents"
ONE-LICENSOR ONE-LICENSOR 90% For the three months ended March 31, 2026 and 2025, one licensor accounted for 100 % of the Company's vendor license agreements (see Note 8) related to the Company's biopharmaceutical operations.

Silo Pharma, Inc. Customers

TickerNameConfidenceEvidence
ONE-LICENSEE ONE-LICENSEE 90% For the three months ended March 31, 2026 and 2025, one licensee accounted for 100 % total revenues from customer license fees.

Silo Pharma, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
SILO-DEBT-12533 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.
SILO-DEBT-12532 Warrants outstanding: 250000 90% xbrl warrant detail from xbrl 2026-03-31.

Silo Pharma, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Silo Pharma, Inc..

Silo Pharma, Inc. Ownership

HolderNameConfidenceEvidence
SILO-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC Geode Capital Management, LLC 95% 13F/ownership overlay lists Geode Capital Management, LLC; shares held 92,905; ownership 0.09%; value $33,055; as of 2025-12-31.
SILO-OWNER-STATE-STREET-CORPORATION State Street Corporation 95% 13F/ownership overlay lists State Street Corporation; shares held 12,500; ownership 0.01%; value $4,447; as of 2025-12-31.
SILO-OWNER-ADVISORSHARES-INVESTMENTS-LLC AdvisorShares Investments, LLC 95% 13F/ownership overlay lists AdvisorShares Investments, LLC; shares held 599,507; ownership 0.60%; value $213,304; as of 2025-12-31.
SILO-OWNER-UBS-GROUP-AG UBS Group AG 95% 13F/ownership overlay lists UBS Group AG; shares held 6,043; ownership 0.01%; value $2,150; as of 2025-12-31.
SILO-OWNER-DRW-SECURITIES-LLC DRW Securities, LLC 95% 13F/ownership overlay lists DRW Securities, LLC; shares held 333,733; ownership 0.34%; value $118,742; as of 2025-12-31.
SILO-OWNER-XTX-TOPCO-LTD Xtx Topco Ltd 95% 13F/ownership overlay lists Xtx Topco Ltd; shares held 56,899; ownership 0.06%; value $20,244; as of 2025-12-31.
SILO-OWNER-SUSQUEHANNA-INTERNATIONAL-GROUP-LLP Susquehanna International Group, LLP 95% 13F/ownership overlay lists Susquehanna International Group, LLP; shares held 29,577; ownership 0.03%; value $10,523; as of 2025-12-31.
SILO-OWNER-VANGUARD-GROUP-INC Vanguard Group Inc 95% 13F/ownership overlay lists Vanguard Group Inc; shares held 24,321; ownership 0.02%; value $8,653; as of 2025-12-31.
SILO-OWNER-VIRTU-FINANCIAL-LLC Virtu Financial LLC 95% 13F/ownership overlay lists Virtu Financial LLC; shares held 18,418; ownership 0.02%; value $6,553; as of 2025-12-31.
SILO-OWNER-JANE-STREET-GROUP-LLC Jane Street Group, LLC 95% 13F/ownership overlay lists Jane Street Group, LLC; shares held 34,373; ownership 0.03%; value $12,229; as of 2025-12-31.

Silo Pharma, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.